ORYZON Announces Topline Results from Phase IIb PORTICO
Company to host Conference Call and live Webcast on Sunday, January 7, 2024 at 5:30 pm PT. An executive summary of the data to be presented at the 7th...
Stay updated with breaking news from Douglasv Faller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company to host Conference Call and live Webcast on Sunday, January 7, 2024 at 5:30 pm PT. An executive summary of the data to be presented at the 7th...
Company to host Conference Call and live Webcast on Sunday, January 7, 2024 at 5:30 pm PT.An executive summary of the data to be presented at the ...
Based on interim efficacy and safety data, Independent Data Monitoring Committee recommends continuation of the trial
Oryzon invests $4.2 million in R&D in the first quarter 2022...
05.05.2022 - Oryzon invests $4.2 million in R&D in the first quarter 2022MADRID, Spain and CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) - Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics ...